日本語English简体中文 繁體中文

4552 JCR Pharmaceuticals Co.,Ltd.JCRファーマTSE Prime / Pharmaceuticals

0 posts

JCR Pharmaceuticals Co.,Ltd. (4552) at a glance

Code
4552
Company
JCR Pharmaceuticals Co.,Ltd.
Local name
JCRファーマ
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥480 -14.0 (-2.83%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

JCR Pharmaceuticals Co.,Ltd. (4552) Stock Price History

JCR Pharmaceuticals Co.,Ltd. closed at ¥480 on Nov 20, 2026, −8.0% over 1 month, −24.4% over 1 year.

2026-10-29 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥544¥480Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥544Oct 30
1-Month Low¥480Nov 20
1-Week Change−3.8%vs Nov 13
1-Month Change−8.0%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥91,954 today (−8.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved −8.0%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥480−14−2.83%
Nov 19 (Thu)¥494−2−0.40%
Nov 18 (Wed)¥496−4−0.80%
Nov 17 (Tue)¥500−5−0.99%
Nov 16 (Mon)¥505+6+1.20%
Nov 13 (Fri)¥499+6+1.22%
Nov 12 (Thu)¥493+0+0.00%
Nov 11 (Wed)¥493−11−2.18%
Nov 10 (Tue)¥504+8+1.61%
Nov 9 (Mon)¥496+8+1.64%
2026-10-29 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥546¥480Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥546Aug 20
3-Month Low¥480Nov 20
1-Month Change−8.0%vs Oct 20
3-Month Change−12.1%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥87,912 today (−12.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −12.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥480−14−2.83%
Nov 19 (Thu)¥494−2−0.40%
Nov 18 (Wed)¥496−4−0.80%
Nov 17 (Tue)¥500−5−0.99%
Nov 16 (Mon)¥505+6+1.20%
Nov 13 (Fri)¥499+6+1.22%
Nov 12 (Thu)¥493+0+0.00%
Nov 11 (Wed)¥493−11−2.18%
Nov 10 (Tue)¥504+8+1.61%
Nov 9 (Mon)¥496+8+1.64%
2026-10-29 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥546¥445May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥546Aug 20
6-Month Low¥445Jun 26
3-Month Change−12.1%vs Aug 20
6-Month Change−2.6%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥97,363 today (−2.6%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved −2.6%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥480−11.8%
Oct 2026¥544+8.4%
Sep 2026¥502−4.0%
Aug 2026¥523+9.2%
Jul 2026¥479+3.5%
Jun 2026¥463−6.8%
May 2026¥497−9.0%
2026-10-29 2027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)¥783¥445Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥783Nov 28
52-Week Low¥445Jun 26
Year to Date−32.6%vs Dec 30
From 52-Week High−38.7%Nov 28

If you had invested ¥100,000 1 year ago, it would be worth ¥75,591 today (−24.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved −24.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥480−11.8%
Oct 2026¥544+8.4%
Sep 2026¥502−4.0%
Aug 2026¥523+9.2%
Jul 2026¥479+3.5%
Jun 2026¥463−6.8%
May 2026¥497−9.0%
Apr 2026¥546−3.9%
Mar 2026¥568−18.2%
Feb 2026¥694+7.6%
Jan 2026¥645−9.4%
Dec 2025¥712−9.1%
Nov 2025¥783―
¥1,307¥421Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥1,307Nov 20, 2023
3-Year Low¥421Apr 7, 2025
Annualized Return−28.4%
Max Drawdown−67.8%

If you had invested ¥100,000 3 years ago, it would be worth ¥36,725 today (−63.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved −63.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥480−32.6%
2025¥712―
¥2,719¥421Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥2,719Jul 18, 2022
5-Year Low¥421Apr 7, 2025
Annualized Return−28.4%
Max Drawdown−84.5%

If you had invested ¥100,000 5 years ago, it would be worth ¥18,838 today (−81.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −81.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥480−32.6%
2025¥712―
¥3,740¥77.5Dec 1, 2005Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥3,740Jun 2021
All-Time Low¥77.5Mar 2009
Total Change+181.1%vs Dec 2005
Annualized Return+5.1%

If you had invested ¥100,000 in Dec 2005, it would be worth ¥281,113 today (+181.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +250.3%, while this stock moved +181.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥480−32.6%
2025¥712+17.3%
2024¥607−48.2%
2023¥1,172−30.3%
2022¥1,681−24.4%
2021¥2,224−8.7%
2020¥2,437+10.0%
2019¥2,215+90.3%
2018¥1,164−12.3%
2017¥1,328+86.3%
2016¥713+7.8%
2015¥661+12.5%
2014¥588+3.1%
2013¥570+80.3%
2012¥316+65.4%
2011¥191−28.7%
2010¥268+4.4%
2009¥257+156.4%
2008¥100−17.3%
2007¥121−3.0%
2006¥125−26.8%
2005¥171―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Dec 2005). Please check the latest prices before trading.

JCR Pharmaceuticals Co.,Ltd. (4552) financial indicators

PER
292.7
PBR
1.43
ROE
0.49%
Dividend yield
4.17%

See all financial indicators for JCR Pharmaceuticals Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of JCR Pharmaceuticals Co.,Ltd. (4552)

Business overview

The company manufactures, purchases and sells prescription drugs, regenerative medicine products and pharmaceutical raw materials. Its group includes ArmaGen, which develops drugs and manages intellectual property and licenses; subsidiaries handling clinical operations, regulatory affairs and development in Brazil and Europe; and AlliedCel, which researches, develops, makes and sells regenerative medicine products. It has a drug development partnership with Medipal Holdings.

Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield4.17%No. 5 in the sector (highest first); median 2.97%
PER292.7xAbove the sector median of 16.5x (No. 34 from the lowest)
PBR1.43xBelow the sector median of 1.86x (No. 25 from the lowest)
ROE0.49%No. 33 in the sector (highest first); median 4.17%
Market cap¥58.7 bnNo. 29 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥7832025/11/28
52-week low¥4456/26
Current position10.4%Where the low is 0% and the high is 100% (close on 11/20: ¥480)
Year to date-32.6%No. 56 of 77 in the sector (best first)
1 year-24.4%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers2 timesLatest: 10/30 (No. 34)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (3).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the JCR Pharmaceuticals Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English